2026-07-21T14:26:55Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/93792025-06-19T09:32:26Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19613

00925njm 22002777a 4500 dc Lobos, José M author Royo-Bordonada, Miguel Angel author Brotons, Carlos author Álvarez-Sala, Luis author Armario, Pedro author Maiques, Antonio author Mauricio, Dídac author Sans, Susana author Villar, Fernando author Lizcano, Angel author Gil-Núñez, Antonio author Álvaro, Fernando de author Conthe, Pedro author Luengo, Emilio author Río, Alfonso Del author Cortés-Rico, Olga author Santiago, Ana de author Vargas, Miguel A author Martínez, Mercedes author Lizarbe, Vicenta author 2008-11 We present the Spanish adaptation from the CEIPC of the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice 2008. This guide recommends the SCORE model for risk evaluation. The aim is to prevent premature mortality and morbidity due to CVD by means of dealing with its related risk factors in clinical practice. The guide focuses on primary prevention and emphasizes the role of the nurses and primary care medical doctors in promoting a healthy life style, based on increasing physical activity, change dietary habits, and non smoking. The therapeutic goal is to achieve a Blood Pressure <140/90 mmHg, but among patients with diabetes, chronic kidney disease, or definite CVD, the objective is <130/80 mmHg. Serum cholesterol should be <200 mg/dl and cLDL <130 mg/dl, although among patients with CVD or diabetes, the objective is <100 mg/dl (80 mg/dl if feasible in very high-risk patients). Patients with type 2 diabetes and those with metabolic syndrome must lose weight and increase their physical activity, and drugs must be administered whenever applicable, with the objective guided by BMI -body mass index- and waist circumference. In diabetic type 2 patients, the objective is glycated haemoglobin <7%. Allowing people to know the guides and developing implementation programs, identifying barriers and seeking solutions for them, are priorities for the CEIPC in order to put the recommendations into practice. Rev Esp Salud Publica. 2008 Nov-Dec;82(6):581-616. 10.1590/s1135-57272008000600002 1135-5727 Revista espanola de salud publica 19180272 http://hdl.handle.net/20.500.12105/9379 Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación Española del CEIPC 2008